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Background. The impact of HIV pre-exposure prophylaxis (PrEP) depends on infections averted by protecting vulnerable indi-
viduals as well as infections averted by preventing transmission by those who would have been infected if not receiving PrEP. 
Analysis of HIV phylogenies reveals risk factors for transmission, which we examine as potential criteria for allocating PrEP.
Methods. We analyzed 6912 HIV-1 partial pol sequences from men who have sex with men (MSM) in the United Kingdom 
combined with global reference sequences and patient-level metadata. Population genetic models were developed that adjust for 
stage of infection, global migration of HIV lineages, and changing incidence of infection through time. Models were extended to 
simulate the effects of providing susceptible MSM with PrEP.
Results. We found that young age <25 years confers higher risk of HIV transmission (relative risk = 2.52 [95% confidence inter-
val, 2.32–2.73]) and that young MSM are more likely to transmit to one another than expected by chance. Simulated interventions 
indicate that 4-fold more infections can be averted over 5 years by focusing PrEP on young MSM.
Conclusions. Concentrating PrEP doses on young individuals can avert more infections than random allocation.
Keywords. HIV; men who have sex with men; phylodynamics; pre-exposure prophylaxis.
 
The effectiveness of public health interventions (PHIs) to 
com bat human immunodeficiency virus (HIV), such as pre- 
exposure prophylaxis (PrEP) with antiretroviral medications 
(ARVs) depends on unknown variability of transmission risk in 
the infected population. The impact of PHIs can be enhanced if 
the intervention can be focused on patients with higher trans-
mission risk, due to, for example, different risk behaviors or 
epidemiological settings [1]. HIV transmission risk is highly 
variable over time, over the course of infection, between risk 
groups, and geographically [2]. Biological, behavioral, and envi-
ronmental factors shape individual HIV transmission risk in 
complex ways. Transmission probabilities per coital act depend 
on viral load [3], sexual positioning [4], male circumcision [5], 
and comorbidities [6]. Viral load is in turn mediated by the 
natural history of HIV infection, and many previous investiga-
tions have elucidated the role of early/acute HIV infection in 
enhancing transmission risk and increasing epidemic spread 
[7–9].
While the factors that shape transmission risk are under-
stood qualitatively, it is challenging to obtain robust quanti-
tative estimates of transmission probabilities or transmission 
risk. HIV genetic sequence data from routine drug resistance 
testing is one of the few sources of widely available observa-
tional data that are directly informative about HIV transmis-
sion patterns and transmission risk [10, 11]. Donor-recipient 
transmission pairs harbor virus that is genetically closely 
related compared to the population as a whole [12, 13]. At 
longer evolutionary time scales, populations or risk groups 
with higher transmission rates will tend to have a paraphyletic 
relationship with populations that are primarily recipients of 
infection. And over long periods of time, HIV genetic diver-
sity is informative about the effective population size of the 
virus and epidemic growth rates [14, 15]. Genetic clustering of 
potential transmission pairs in large HIV sequence databases 
is a simple and scalable approach to characterizing transmis-
sion patterns [16], but genetic clustering is a highly unreliable 
proxy for transmission risk and inferences based on clusters 
are known to be biased by correlations with stage of infection 
at time of sampling [17–20]. In this study, we computed genetic 
clusters for a large sample of HIV-1 subtype B sequences in 
the United Kingdom and used these results to heuristically 
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identify factors that may enhance individual-level transmis-
sion risk, with a particular focus on the role of young age on 
mediating HIV transmission in men who have sex with men 
(MSM). For selected variables with significant clustering asso-
ciations, we performed a more robust phylodynamic analysis 
using formal phylogenetic and population genetic modeling 
[21]. Well-designed population genetic models can account for 
observed genetic diversity resulting from differential sampling 
effort over time [22] and between risk groups [23], and can 
account for nonlinear epidemic dynamics through time [24]. 
This analysis provided estimates of transmission risk ratios for 
selected biological and demographic covariates, which in turn 
informed a mathematical model of a PrEP intervention.
METHODS
Data
The UK HIV Drug Resistance Database contains more than 
100 000 sequences from more than 60 000 patients at the end 
of 2015 (http://www.hivrdb.org.uk/). We extracted 6912 par-
tial pol HIV-1 sequences and associated metadata (patient-
level variables) that met the following criteria: (1) the sequence 
was subtype B determined using REGA [25]; (2) the sequence 
length was >1200 nucleotides; (3) the patient reported being 
MSM; and (4) the patient was treatment naive. We excluded 
all but the first sequence per patient if multiple sequences are 
available. We further restricted our analysis to samples that had 
a CD4 and/or recent infection testing algorithm (RITA) [26] 
result within 1  year of the sequence sample date in order to 
adjust for the effect of recency of infection on clustering and 
phylodynamic analyses. Sequences were collected between 
1991 and the end of 2014 with 50% of samples collected 
after 2009.
To account for importation of HIV lineages, we added 1006 
subtype B global reference sequences corresponding to unique 
sequences with highest similarity (using bitscore) after a BLAST 
search for each of the UK sequences. The BLAST database 
comprised 18 544 global reference sequences (excluding UK 
sequences) obtained from Los Alamos HIV sequence data-
base (https://www.hiv.lanl.gov, accessed October 2016). Drug 
resistance mutation sites as listed in the 2015 update from the 
International Antiviral Society-USA [27] were stripped from 
the alignment using the R package big.phylo (https://github.
com/olli0601/big.phylo).
Multiple demographic and clinical covariates were available 
for each patient from Public Health England’s (PHE’s) HIV and 
AIDS Reporting System (HARS), which included persons diag-
nosed with HIV and seen for care. These data were linked to the 
UK Resistance database and included: (1) region of diagnosis 
corresponding to 12 reporting regions of PHE in the United 
Kingdom, (2) year of birth, (3) ethnicity, (4) CD4 counts, and 
(5) viral loads.
The work was conducted as part of the National Institute 
for Health Research Health Protection Research Unit (NIHR 
HPRU) at Imperial College London (Modelling Methodology), 
a partnership with PHE.
Genetic Clustering
Heuristic genetic clustering analyses were carried out using 
threshold evolutionary distance, as described in [13]. Clusters 
were computed using thresholds of 0.5% and 1.5% distance 
using a TN93 substitution model, and sequence ambiguities 
were averaged when computing evolutionary distances between 
sequences. To identify variables that may be related to trans-
mission risk, univariate logistic regression models were used 
to quantify the relative risk of clustering at different genetic 
distance thresholds. Multivariate logistic regression mod-
els including an indicator for early HIV infection (EHI) were 
used to adjust for upwards skew in frequency of clustering of 
recent HIV infections [20]. Young men who have sex with men 
(YMSM) were defined as patients with sequences sampled while 
the patient had an age less than 25 years, which corresponds to 
the bottom 10.7% of the age distribution. Both age at time of 
sampling and absolute age (corresponding to year of birth) may 
be important determinants of evolutionary history of an HIV 
lineage; however, we defined YMSM based on age at sampling 
because we anticipate this variable to have stronger association 
with recent transmission history of that lineage. The age thresh-
old for defining YMSM is shared by recent studies [28] and was 
motivated by observed increasing odds of clustering with young 
age and the objective of identifying a relatively small risk group 
that would benefit from PrEP prioritization.
Phylogenetic Analysis
Phylogenetic trees were estimated by maximum likelihood 
using ExaML and the R package big.phylo with a general time 
reversible model of nucleotide substitution and gamma distri-
bution for rate heterogeneity among sites [29]. One hundred 
trees were reconstructed from bootstrap alignment. Three sub-
type G reference strains from Los Alamos database were used as 
outgroup for rooting the subtype-specific trees.
Molecular Clock
We calculated root-to-tip distance from the phylogenetic tree 
and regressed distance by time of sampling. By iterations of 
Grubb’s algorithm [30] (https://CRAN.R-project.org/pack-
age=outliers), we identified and excluded 0.3% sequences as 
outliers in terms of divergence time and evolutionary rate. We 
applied least-square dating (LSD) algorithm [31] on rooted 
trees and sampling times to estimate the substitution rate and 
dates of ancestral nodes. To ensure accuracy of time-scaled phy-
logenies, the fast LSD method was compared to slower state of 
the art Bayesian methods (BEAST) [32] for a single clade using 
lineage-through-time statistics. Estimated lineages through 
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time using LSD and BEAST are compared in the Supplementary 
information.
To facilitate computation with very large phylogenies, we 
divided the maximum likelihood tree into 21 disjoint clades 
defined by threshold time to most recent common ancestor 
(TMRCA). The threshold TMRCA was chosen such that the 
maximum number of sampled lineages in any clade was fewer 
than 1000 and the minimum clade size was 300. All clades had 
a TMRCA before 1980 and thus larger clades included both 
closely and distantly related sequences. Clades should not be 
confused with genetic distance clusters. Phylodynamic analyses 
were run in parallel on each clade.
Phylodynamic Analysis
A structured coalescent model [33] was developed to estimate 
transmission risk ratios from the time-stamped HIV phylogeny 
while adjusting for stage of infection at time of sampling and 
differential sampling effort among young MSM and the remain-
ing population. To adjust for stage of infection, we assigned 
each lineage to a CD4 stage described by Cori et  al [34]. We 
defined the EHI stage to include both recent/acute infection 
and patients with high CD4 >500. Thus the EHI period is likely 
to encompass more than a year of the initial infectious period 
for most patients. Stage assignments were based on the CD4 
result collected nearest in time to sequence sampling (maxi-
mum 1 year) as well as the RITA test result if available.
To model the dynamics of the number of infections and 
transmission rates within and between each deme, we devel-
oped a compartmental infectious disease model consisting of 
7 ordinary differential equations, which described the number 
of infections in each of 3 stages of infection and 2 transmission 
risk levels corresponding to age group. The transmission rate 
was modeled as a product of 3 factors: (1) risk level according 
to a binary covariate such as being a young MSM; (2) stage of 
infection (EHI, chronic, or AIDS); and (3) secular trends in 
transmission rate. We modeled incidence of infection in each 
clade using a susceptible-infected-removed (SIR) model and 
estimated susceptible population size and transmission rate 
separately in each clade.
Importation of lineages into the United Kingdom was mod-
eled using a single deme to represent the global HIV reservoir. 
The reservoir deme was designed to have exponentially growing 
effective population size with 2 free parameters which were esti-
mated independently using a skyspline model [35]. Importation 
from the reservoir is modeled as a source-sink relationship 
with a constant rate per lineage. Once a lineage migrates from 
the reservoir, we assume that it may not circulate back to the 
reservoir.
Whereas transmission patterns between age groups may be 
highly nonrandom [36, 37] and transmissions are more likely 
between people in similar age groups, 2 additional parameters 
were estimated that describe the conditional probability of a 
YMSM transmitting to another YMSM and the probability of 
an older MSM (OMSM) transmitting to a YMSM.
Coalescent analyses were implemented using the phydynR R 
package (https://github.com/emvolz-phylodynamics/phydynR) 
and model parameters were estimated using maximum likeli-
hood. Confidence intervals (CI) for transmission risk ratios of 
EHI and YMSM, age assortativity parameters, and exogenous lin-
eage importation rates were computed using likelihood profiles.
A complete specification of the model equations, code, and 
estimation methodology is available in the Supplementary 
information.
Predicting PrEP Intervention Effectiveness
We simulated a PrEP intervention based on provision of ARVs 
to approximately 15 000 susceptible individuals who are vul-
nerable to HIV infection. This strategy is a modest scale-up of 
current plans to provide PrEP to 10 000 eligible individuals over 
3 years [38].
Two scenarios were considered in order to evaluate the ben-
efit of prioritizing YMSM with higher risk of both infection 
and transmission. In the first scenario, PrEP was randomly 
allocated to all MSM irrespective of age, and in the second 
scenario, all PrEP was allocated to YMSM. Note that PrEP 
will not be allocated completely at random, and the first sce-
nario is used as a benchmark rather than to model a likely 
outcome or standard of care. All simulations assumed 90% 
effectiveness in preventing infection. The population-level 
impact of PrEP depends on the proportion of susceptible 
individuals treated, and the number of susceptible MSM 
was extrapolated from recent HIV prevalence estimates and 
number diagnosed in the United Kingdom [39]. Given an 
estimated 45 000 MSM diagnosed and undiagnosed living 
with HIV at the end of 2014 and HIV prevalence among 
MSM aged 15–44 between 4.1% and 5.8%, we infer there to 
be between 731 000 and 1.05 million susceptible MSM. We 
therefore examined a range of proportions receiving PrEP 
of 1.4%–2.1% for all MSM or alternatively 13.4%–19.2% of 
YMSM. This simulation exercise did not account for self- 
medication with PrEP or potential differences in self-prophy-
laxis between age groups. The number of new HIV infections 
was simulated under both scenarios over a 5-year horizon by 
modifying the mathematical model fitted to HIV phylogenies 
and reducing transmission rates in proportion to the number 
of susceptibles receiving PrEP.
RESULTS
Relative to older age groups, YMSM were more likely to be sam-
pled with recent infection corresponding to higher CD4s and 
more frequent RITA-positive test results (Table 1). YMSM had 
significantly higher rates of EHI defined as CD4>500 or RITA 
positive test result (41% versus 23%, 2-sample binomial test). 
YMSM of subtype B were also more likely to reside outside of 
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the London metropolitan area and less likely to be born outside 
of the United Kingdom. Relative to OMSM, YMSM were more 
likely to be genetically clustered with at least 1 other patient 
(31% versus 20%). More than 60% of both YMSM and OMSM 
clustered with at least 1 other patient using 1.5% threshold 
evolutionary distance and at 0.5% threshold distance about a 
quarter of patients clustered. Small but statistically significant 
associations were found between the odds of clustering at 0.5% 
and 1.5% evolutionary distance and EHI, age, and location of 
sampling. Patients sampled with EHI clustered slightly more in 
multivariate analyses (odds ratio [OR] = 1.14, 0.5% threshold) 
as do YMSM (OR = 1.09, 0.5% threshold).
Coalescent-based phylodynamic analysis showed strong evi-
dence of higher transmission risk for both EHI and YMSM. 
The transmission risk ratio of YMSM relative to all other MSM 
(OMSM) is 2.52 (95% CI, 2.32–2.73). The transmission risk 
ratio of EHI (CD4  >500 and/or RITA positive) relative to all 
other stages of infection is 3.70 (95% CI, 3.36–4.09). These rep-
resent independent effects, and YMSM with EHI were predicted 
to have the highest transmission risk.
The phylodynamic analysis also revealed highly nonrandom 
transmission patterns by age. The probability that the recipient 
is YMSM given an infected donor in the OMSM risk group was 
20.0% (95% CI, 17.7%–22.7%), which is roughly twice the pro-
portion of the population that is YMSM (approximately 10% 
of MSM by definition). However, the probability that the recip-
ient is YMSM given a YMSM donor was very much higher: 
83.3% (95% CI, 78.4%–87.2%). Consequently, most YMSM 
were infected by other YMSM and not by older age groups. 75% 
of infections in YMSM were attributable to other YMSM, and 
87% of infections in OMSM were attributable to other OMSM. 
Age assortativity and transmission patterns are summarized in 
Figure 1.
Finally, we estimated the average time that a HIV lineage 
has circulated in the United Kingdom prior to sampling. This 
was 27.6 years (95% CI, 26.6–28.75), suggesting that most sub-
type B infections in MSM are derived from introductions that 
occurred in the late 1980s [14].
The fitted population genetic model provided estimates of 
the number of effective infections through time (Figure 1 and 
Supplementary Figure S1) which approximately corresponds 
to the number of MSM living with HIV within the 21 clades 
included in this analysis. Note that these estimates were based 
on a subset of all HIV-1 genetic diversity and the absolute num-
ber of infections does not correspond to the total number of 
infections in the population. Nevertheless, the estimated rates 
of growth of MSM living with HIV are similar to estimates 
obtained by Public Health England based on surveillance data 
(Figure 1B and Supplementary Figure S2). We estimated that the 
21 clades included samples from 60% of people living with HIV 
descended from the clades, the remainder not meeting inclusion 
criteria, not having sequences, or not being diagnosed in the 
United Kingdom. Note that the sample proportion is influenced 
by the fact that approximately 80% are diagnosed, not all diag-
nosed have a sequence in the database, and approximately 50% 
of lineages were excluded due to lack of adequate biomarkers 
or because they were collected from ART-experienced patients. 
There was substantial variation in the proportion of each clade 
that are YMSM, and the proportion of transmissions attribut-
able to YMSM in each clade (Figure 1). The proportion of the 
clade that was YMSM was not significantly associated with 
growth rates of effective infections in each clade (F test P = .42).
Simulated PrEP interventions based on the fitted popula-
tion genetic model showed large gains from focusing PrEP on 
YMSM in comparison to random allocation to all MSM. Note 
that, in reality, PrEP would not be allocated randomly, and ran-
dom allocation should be interpreted as a benchmark rather 
than a likely outcome or standard of care. Figure 2 shows the 
predicted cumulative infections averted by PrEP over 5  years 
if 15 000 susceptible individuals were provided PrEP in 2015, 
which was the end point for sequence data included in this 
study. Simulations reflect not only direct impacts from prevent-
ing infections in treated individuals, but also indirect effects 
from preventing transmission by individuals who would have 
become infected without PrEP. We predicted that 749 (636–857) 
infections would be averted over 5 years if PrEP was focused 
on YMSM and that 179 (150–207) infections would be averted 
with random allocation. PrEP for YMSM averted 4.2 times as 
many infections over 5 years as random allocation.
DISCUSSION
The combination of high levels of transmission and high assor-
tativity amplifies incidence in YMSM and PrEP effectiveness in 
YMSM. PrEP in YMSM averts transmissions that would occur 
Table 1. Demographic and Clinical Characteristics of YMSM and OMSM 





All MSM  
(n = 30 711)
Year of birth (IQR) 1987(1984–1990) 1971(1964–1977) 1971(1964–1979)
CD4 (IQR) 469(337–620) 415(259–583) 420(260–590)
RITA+ 34% 25% 28%
London 39% 55% 59%
White 84% 88% 85%
Immigrant 19% 26% 30%
Clustered (0.5%) 31% 20%
Clustered (1.5%) 77% 62%
YMSM and OMSM count only patients that meet  all inclusion criteria. Statistical tests 
compare YMSM/B or OMSM/B and all MSM, except for the clustered outcome for which 
YMSM and OMSM are compared. Significance levels were determined using a 2-sample t 
test for continuous variables and Fishers exact test for binary variables.
Entries in bold have a P value < .001.
Abbreviations: IQR, interquartile range; OMSM, older men who have sex with men; 
YMSM, young men who have sex with men.
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if YMSM were infected, and because YMSM are more likely to 
infect one another, subsequent generations of the epidemic pro-
cess are further reduced. These transmission patterns yield higher 
incidence in YMSM, and it remains to corroborate observations 
based on phylodynamic analysis by estimating age-specific inci-
dence in UK MSM from nongenetic surveillance data.
HIV genetic diversity in the United Kingdom showed a clear 
pattern consistent with higher risk of infection in YMSM and 
higher risk of transmission EHI. The effect of young age on 
transmission risk remained after controlling for higher rates 
of EHI among patients diagnosed at young age. YMSM have 
the hallmarks of a small high-risk core group [40], having both 
higher intrinsic transmission rates and preferential attachment 
within the risk group. YMSM show very high levels of assort-
ative mixing. Most infections (75%) in YMSM arose via inter-
action with other YMSM despite comprising around 10% of 
the infected MSM population. These findings are consistent 
with previous reports of higher rates of HIV genetic clustering 
in YMSM [41, 42]. We find evidence for a modest net flow of 
transmissions from OMSM to YMSM which is in line with the 
findings of age-discordant clustering among young MSM found 
by Wolf et al [28]. These transmission patterns also differ from 
studies of genetic clustering in heterosexual populations, which 
have shown much greater age-discordancy within clusters that 
is hypothesized to arise from net flows of transmission from 
older males to younger females [43].
In reality, PrEP will not be allocated randomly, and age 
may provide one of many criteria for PrEP. Further studies 
are warranted to examine how age can be used in combina-
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Figure 1. Effective number of infections through time, cumulative sequences sampled through time, and proportion of transmissions attributable to young men who have 
sex with men (YMSM) for 21 subtype B clades in UK MSM. A, Effective infections and cumulative samples combined for 21 clades. B, Number of MSM living with human 
immunodeficiency virus (HIV) estimated from surveillance data between 2004 and 2012 [39] versus phylodynamic estimates (log-transformed). A  regression with slope 
constrained to 1 is shown in red. C, The estimated proportion of transmissions attributable to YMSM (age <25) for 21 clades and the number of samples in each clade. D, 
Estimated transmission patterns between YMSM and other MSM (OMSM). Left: The probability that a recipient is in each age group given that a donor is either YMSM or 

















Figure 2. The number of infections averted over a 5-year horizon using a random 
allocation of pre-exposure prophylaxis (PrEP) or a targeted PrEP strategy focused on 
young men who have sex with men.
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randomized clinical trials have examined the direct protec-
tive effects of PrEP in MSM but have not accounted for indi-
rect transmission effects included in our simulations [44, 45]. 
Clinical trials, including studies conducted with UK MSM [46], 
have focused on individuals at higher risk of infection than 
MSM as a whole (eg, those with recent sexually transmitted 
infection [STI] testing history and condomless sex), so that esti-
mates of infections averted are not directly comparable with our 
simulation results, which were constrained by the available data 
to focus on random allocation within age groups.
This study only examined subtype B sequences, which com-
prise the large majority of sequences among MSM in the United 
Kingdom. Less-prevalent subtypes have different demographic 
and clinical characteristics, notably CRF02AG which has higher 
proportions of recent African migrants (results not shown), and 
these results may not generalize to those clades. Compared to all 
sequences from MSM, the HIV lineages included in this analy-
sis come from patients that are less likely to reside in London or 
be foreign born (Table 1).
Young age in MSM is a simple and easily identifiable proxy 
for transmission risk that may form one of many inputs into 
algorithms for prioritizing or promoting PrEP. Parameters 
estimated in this study may provide useful inputs into more 
detailed simulations for designing realistic PrEP interventions 
[47]. Access to PrEP and knowledge of PrEP may be lower in 
young MSM [48], providing further impetus to provide benefits 
for that group. YMSM can not be prioritized to the exclusion 
of other age groups, nor should age be the sole criterion used. 
Many risk groups were not considered in this phylogenetic 
analysis and it is important to have diverse as well as focused 
allocation of PrEP [49]. Other variables, such as recent STI test-
ing history or self-reported risk exposures, are likely to also cor-
relate highly with transmission risk, and it remains to examine 
such covariates within a phylodynamics framework.
Supplementary Data
Supplementary materials are available at The Journal of Infectious 
Diseases online. Consisting of data provided by the authors to 
benefit the reader, the posted materials are not copyedited and 
are the sole responsibility of the authors, so questions or com-
ments should be addressed to the corresponding author.
Notes
Acknowledgments. This research was made possible by the 
Steering Committee and Coordinating Centre of the UK Drug 
Resistance Database the Centres contributing data to the UK 
Drug Resistance Database. A full list of contributors is provided 
in the online Supporting material.
Funding. This work was supported by the UK Health 
Protection Research Units in Modeling Methodology and 
Sexually Transmitted Infections and by the National Institutes 
of Health (grant number R01AI087520).
Potential conflicts of interest. All authors: No reported con-
flicts of interest. All authors have submitted the ICMJE Form 
for Disclosure of Potential Conflicts of Interest. Conflicts that 
the editors consider relevant to the content of the manuscript 
have been disclosed.
References
 1. Abu-Raddad LJ. Role of acute HIV infection in driving HIV 
transmission: implications for HIV treatment as preven-
tion. PLoS Med 2015; 12:e1001803.
 2. Chemaitelly H, Awad SF, Abu-Raddad LJ. The risk of HIV 
transmission within HIV-1 sero-discordant couples appears 
to vary across sub-Saharan Africa. Epidemics 2014; 6:1–9.
 3. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and 
heterosexual transmission of human immunodeficiency 
virus type 1.  Rakai Project Study Group. N Engl J Med 
2000; 342:921–9.
 4. Boily MC, Baggaley RF, Wang L, et  al. Heterosexual risk 
of HIV-1 infection per sexual act: systematic review and 
meta-analysis of observational studies. Lancet Infect Dis 
2009; 9:118–29.
 5. Wawer MJ, Makumbi F, Kigozi G, et  al. Circumcision in 
HIV-infected men and its effect on HIV transmission to 
female partners in Rakai, Uganda: a randomised controlled 
trial. Lancet 2009; 374:229–37.
 6. Baeten JM, Overbaugh J. Measuring the infectiousness of 
persons with HIV-1: opportunities for preventing sexual 
HIV-1 transmission. Curr HIV Res 2003; 1:69–86.
 7. Hollingsworth TD, Pilcher CD, Hecht FM, Deeks SG, Fraser 
C. High transmissibility during early HIV infection among 
men who have sex with men-San Francisco, California.  
J Infect Dis 2015; 211:1757–60.
 8. Volz EM, Ionides E, Romero-Severson EO, Brandt MG, 
Mokotoff E, Koopman JS. HIV-1 transmission during 
early infection in men who have sex with men: a phylody-
namic analysis. PLoS Med 2013; 10:e1001568; discussion 
e1001568.
 9. Marzel A, Shilaih M, Yang WL, et  al.; Swiss HIV Cohort 
Study. HIV-1 Transmission during recent infection and 
during treatment interruptions as major drivers of new 
infections in the Swiss HIV Cohort Study. Clin Infect Dis 
2016; 62:115–22.
 10. Dennis AM, Herbeck JT, Brown AL, et  al. Phylogenetic 
studies of transmission dynamics in generalized HIV epi-
demics: an essential tool where the burden is greatest?  
J Acquir Immune Defic Syndr 2014; 67:181–95.
 11. Pillay D, Herbeck J, Cohen MS, et  al.; PANGEA-HIV 
Consortium. PANGEA-HIV: phylogenetics for generalised 
epidemics in Africa. Lancet Infect Dis 2015; 15:259–61.
 12. Romero-Severson E, Skar H, Bulla I, Albert J, Leitner T. Timing 
and order of transmission events is not directly reflected in a 
pathogen phylogeny. Mol Biol Evol 2014; 31:2472–82.
Downloaded from https://academic.oup.com/jid/article-abstract/217/10/1522/4915980
by University College London user
on 20 June 2018
1528 • JID 2018:217 (15 May) • Volz et al
 13. Wertheim JO, Leigh Brown AJ, Hepler NL, et  al. The 
global transmission network of HIV-1. J Infect Dis 2014; 
209:304–13.
 14. Hué S, Pillay D, Clewley JP, Pybus OG. Genetic analy-
sis reveals the complex structure of HIV-1 transmission 
within defined risk groups. Proc Natl Acad Sci U S A 2005; 
102:4425–9.
 15. Faria NR, Rambaut A, Suchard MA, et  al. HIV epidemi-
ology. The early spread and epidemic ignition of HIV-1 in 
human populations. Science 2014; 346:56–61.
 16. Poon AF, Gustafson R, Daly P, et al. Near real-time monitoring 
of HIV transmission hotspots from routine HIV genotyping: 
an implementation case study. Lancet HIV 2016; 3:e231–8.
 17. Le Vu S, Ratmann O, Delpech V, et al. Comparison of clus-
ter-based and source-attribution methods for estimating 
transmission risk using large HIV sequence databases [pub-
lished online ahead of print 20 October, 2017]. Epidemics 
doi: 10.1016/j.epidem.2017.10.001.
 18. Dearlove BL, Xiang F, Frost SDW. Biased phylodynamic 
inferences from analysing clusters of viral sequences. Virus 
Evol 2017; 3:vex020.
 19. Poon AF. Impacts and shortcomings of genetic clustering 
methods for infectious disease outbreaks. Virus Evol 2016; 
2:vew031.
 20. Volz EM, Koopman JS, Ward MJ, Brown AL, Frost SD. 
Simple epidemiological dynamics explain phylogenetic 
clustering of HIV from patients with recent infection. PLoS 
Comput Biol 2012; 8:e1002552.
 21. Volz EM, Koelle K, Bedford T. Viral phylodynamics. PLoS 
Comput Biol 2013; 9:e1002947.
 22. Volz EM, Frost SD. Sampling through time and phylody-
namic inference with coalescent and birth-death models.  
J R Soc Interface 2014; 11:20140945.
 23. De Maio N, Wu CH, O’Reilly KM, Wilson D. New routes to 
phylogeography: a bayesian structured coalescent approxi-
mation. PLoS Genet 2015; 11:e1005421.
 24. Ratmann O, Hodcroft EB, Pickles M, et al.; PANGEA-HIV 
Consortium. Phylogenetic tools for generalized HIV-1 epi-
demics: findings from the PANGEA-HIV methods compar-
ison. Mol Biol Evol 2017; 34:185–203.
 25. Pineda-Peña AC, Faria NR, Imbrechts S, et al. Automated 
subtyping of HIV-1 genetic sequences for clinical and sur-
veillance purposes: performance evaluation of the new 
REGA version 3 and seven other tools. Infect Genet Evol 
2013; 19:337–48.
 26. Aghaizu A, Murphy G, Tosswill J, et  al. Recent infection 
testing algorithm (RITA) applied to new HIV diagnoses in 
England, Wales and Northern Ireland, 2009 to 2011. Euro 
Surveill 2014; 19:20673.
 27. Wensing AM, Calvez V, Günthard HF, et al. 2015 update of 
the drug resistance mutations in HIV-1. Top Antivir Med 
2015; 23:132–41.
 28. Wolf E, Herbeck JT, Van Rompaey S, et al. Short commu-
nication: phylogenetic evidence of HIV-1 transmission 
between adult and adolescent men who have sex with men. 
AIDS Res Hum Retroviruses 2017; 33:318–22.
 29. Kozlov AM, Aberer AJ, Stamatakis A. ExaML version 
3: a tool for phylogenomic analyses on supercomputers. 
Bioinformatics 2015; 31:2577–9.
 30. Grubbs FE. Sample criteria for testing outlying observa-
tions. Ann Math Stat 1950; 21:27–58.
 31. To TH, Jung M, Lycett S, Gascuel O. Fast dating using 
least-squares criteria and algorithms. Syst Biol 2016; 
65:82–97.
 32. Drummond AJ, Suchard MA, Xie D, Rambaut A. Bayesian 
phylogenetics with BEAUti and the BEAST 1.7. Mol Biol 
Evol 2012; 29:1969–73.
 33. Volz EM. Complex population dynamics and the coalescent 
under neutrality. Genetics 2012; 190:187–201.
 34. Cori A, Pickles M, van Sighem A, et al. CD4+ cell dynam-
ics in untreated HIV-1 infection: overall rates, and effects 
of age, viral load, sex and calendar time. AIDS 2015; 
29:2435–46.
 35. Volz EM, Romero-Severson E, Leitner T. Phylodynamic 
inference across epidemic scales. Mol Biol Evol 2017; 
34:1276–88.
 36. Prah P, Copas AJ, Mercer CH, Nardone A, Johnson AM. 
Patterns of sexual mixing with respect to social, health 
and sexual characteristics among heterosexual couples 
in England: analyses of probability sample survey data. 
Epidemiol Infect 2015; 143:1500–10.
 37. Phillips AN, Cambiano V, Nakagawa F, et al. Increased HIV 
incidence in men who have sex with men despite high levels 
of ART-induced viral suppression: analysis of an extensively 
documented epidemic. PLoS One 2013; 8:e55312.
 38. NHS England. NHS England announces world’s largest single 
PrEP implementation trial to prevent HIV infection, 2017. 
https://www.england.nhs.uk/2017/08/nhs-england-an-
nounces-worlds-largest-single-prep-implementation-tri-
al-to-prevent-hiv-infection/. Accessed 10 February 2018.
 39. Skingsley A, Yin Z, Kirwan P, et al. HIV in the UK–Situation 
Report 2015: data to end 2014. London: Public Health 
England, 2015.
 40. Caldarelli G, Catanzaro M. Networks: A very short intro-
duction. Oxford: Oxford University Press, 2012.
 41. Pao D, Fisher M, Hué S, et al. Transmission of HIV-1 during 
primary infection: relationship to sexual risk and sexually 
transmitted infections. AIDS 2005; 19:85–90.
 42. Lubelchek RJ, Hoehnen SC, Hotton AL, Kincaid SL, Barker 
DE, French AL. Transmission clustering among newly 
diagnosed HIV patients in Chicago, 2008 to 2011: using 
phylogenetics to expand knowledge of regional HIV trans-
mission patterns. J Acquir Immune Defic Syndr 2015; 
68:46–54.
Downloaded from https://academic.oup.com/jid/article-abstract/217/10/1522/4915980
by University College London user
on 20 June 2018
Heterogeneous Transmission Risk of HIV • JID 2018:217 (15 May) • 1529
 43. de Oliveira T, Kharsany AB, Gräf T, et al. Transmission net-
works and risk of HIV infection in KwaZulu-Natal, South 
Africa: a community-wide phylogenetic study. Lancet HIV 
2017; 4:e41–50.
 44. Grant RM, Lama JR, Anderson PL, et al.; iPrEx Study Team. 
Preexposure chemoprophylaxis for HIV prevention in men 
who have sex with men. N Engl J Med 2010; 363:2587–99.
 45. Buchbinder SP, Glidden DV, Liu AY, et  al. HIV pre-ex-
posure prophylaxis in men who have sex with men and 
transgender women: a secondary analysis of a phase 3 ran-
domised controlled efficacy trial. Lancet Infect Dis 2014; 
14:468–75.
 46. McCormack S, Dunn DT, Desai M, et  al. Pre-exposure 
prophylaxis to prevent the acquisition of HIV-1 infection 
(PROUD): effectiveness results from the pilot phase of 
a pragmatic open-label randomised trial. Lancet 2016; 
387:53–60.
 47. Cambiano V, Miners A, Dunn D, et al. Cost-effectiveness 
of pre-exposure prophylaxis for HIV prevention in men 
who have sex with men in the UK: a modelling study 
and health economic evaluation. Lancet Infect Dis 2018; 
18:85–94.
 48. Bauermeister JA, Meanley S, Pingel E, Soler JH, Harper 
GW. PrEP awareness and perceived barriers among single 
young men who have sex with men. Curr HIV Res 2013; 
11:520–7.
 49. The Lancet HIV. Better late than never: PrEP in England. 
Lancet HIV 2017; 4:e1.
Downloaded from https://academic.oup.com/jid/article-abstract/217/10/1522/4915980
by University College London user
on 20 June 2018
